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Abstract
Background: Laparoscopic surgery for T4 colon cancer may be safe in selected patients. We hypothesized that
small tumor size might preoperatively predict a good laparoscopic surgery outcome. Herein, we compared the
clinicopathologic and oncologic outcomes of laparoscopic and open surgery in small T4 colon cancer.
Methods: In a retrospective multicenter study, we reviewed the data of 449 patients, including 117 patients with
tumors ≤ 4.0 cm who underwent surgery for T4 colon cancer between January 2014 and December 2017. We
compared the clinicopathologic and 3-year oncologic outcomes between the laparoscopic and open groups.
Survival curves were estimated using the Kaplan–Meier method and compared using the log-rank test. Univariate
and multivariate analyses were performed using the Cox proportional hazards model. A p < 0.05 was considered
statistically significant.
Results: Blood loss, length of hospital stay, and postoperative morbidity were lower in the laparoscopic group than
in the open group (median [range], 50 [0–700] vs. 100 [0–4000] mL, p < 0.001; 8 vs. 10 days, p < 0.001; and 18.0 vs.
29.5%, p = 0.005, respectively). There were no intergroup differences in 3-year overall survival or disease-free survival
(86.6 vs. 83.2%, p = 0.180, and 71.7 vs. 75.1%, p = 0.720, respectively). Among patients with tumor size ≤ 4.0 cm,
blood loss was significantly lower in the laparoscopic group than in the open group (median [range], 50 [0–530] vs.
50 [0–1000] mL, p = 0.003). Despite no statistical difference observed in the 3-year overall survival rate (83.3 vs.
78.7%, p = 0.538), the laparoscopic group had a significantly higher 3-year disease-free survival rate (79.2 vs. 53.2%,
p = 0.012).
Conclusions: Laparoscopic surgery showed similar outcomes to open surgery in T4 colon cancer patients and may
have favorable short-term oncologic outcomes in patients with tumors ≤ 4.0 cm.
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Background
Approximately 10–20% of patients with colon cancer are
diagnosed with T4 colon cancer [1–3]. R0 resection is
essential for curative surgery in T4 colon cancer, al-
though R0 resection is not easily achieved in case of
tumor invasion into the adjacent organs or structures.
Several meta-analyses and randomized controlled trials
[4–7] have reported that laparoscopic surgery is non-
inferior to open surgery for colon cancer. However, in
T4 colon cancer, the feasibility of laparoscopic surgery
with regard to oncologic outcomes remains debatable. In
addition, treatment guidelines recommend an open ap-
proach for pathological T4 colon cancer.
Several recent studies [8–10] have reported that lap-
aroscopic surgery for T4 colon cancer had better short-
term outcomes (e.g., less intraoperative blood loss and
shorter hospital stay) than open surgery, as well as non-
inferiority in oncologic outcomes. However, the exact
clinical conditions wherein laparoscopic surgery for T4
colon cancer is feasible or harmful, with regard to onco-
logic outcomes, need to be ascertained. Studies [11, 12]
have reported that a technical difficulty during laparo-
scopic surgery could threaten oncological safety, while
tumor size is a factor that is known to influence the
technical difficulty associated with tumor resection.
In T4 colon cancer, a laparoscopic approach seems to
be superior in regard to clinical outcomes in cases where
the tumor is easy to access or handle, such as with a
small invasive tumor. However, large-sized tumors are
more difficult to resect laparoscopically, which may in-
crease the risk of tumor spillage. However, there is scant
evidence of the comparative outcomes of laparoscopic
and open surgery with respect to the tumor size in T4
colon cancer.
In this study, we investigated the hypothesis that
tumor size may influence the preoperative prediction of
a favorable outcome following a laparoscopic approach
and evaluated the clinicopathologic and oncologic out-
comes of laparoscopic and open surgery in patients with
small T4 colon cancer.
Methods
Patient characteristics
A retrospective chart review and analysis of multicenter
data were undertaken, including data from patients diag-
nosed with pathological T4 colon cancer who underwent
curative surgery at three institutions between January
2014 and December 2017. Rectal cancer was defined as
cancer in which the lower margin of the tumor was lo-
cated within 15.0 cm above the anal verge, and patients
with rectal cancer were excluded from this study. More-
over, patients with T1–3 colon cancer, a histological
diagnosis indicating cancer other than adenocarcinoma,
palliative surgery, inflammatory bowel disease, or heredi-
tary colon cancer were excluded.
The patient characteristics and perioperative out-
comes were analyzed, including age, gender, body
mass index (BMI), American Society of Anesthesiolo-
gists (ASA) score, preoperative carcinoembryonic anti-
gen level, tumor location, operative time, blood loss,
intraoperative transfusion, length of hospital stay, and
postoperative morbidity. The pathologic features that
were analyzed included tumor size, T stage, nodal sta-
tus, angiolymphatic invasion, venous invasion, peri-
neural invasion, adjacent organ resection, and R0
resection. The tumor size was measured on the basis
of the long diameter of the tumor in the pathologic
specimen. Patients with ASA scores of 1–2 and 3–4
were included in the same group for analysis. The
tumor location was divided into the right (from the
cecum to the transverse colon) and left (from the
splenic flexure to the sigmoid colon) sides. The nodal
status was classified as the absence (N0) or presence
(N+) of metastatic regional lymph node(s).
All surgeons who participated in the study were ex-
perts who had performed laparoscopic or open colo-
rectal surgery for > 10 years. Laparoscopic or open
surgery was performed according to each surgeon’s
preference.
Outcomes
The primary outcome of this study was the comparison
of oncologic outcomes, including 3-year overall survival
(OS) and 3-year disease-free survival (DFS), between the
laparoscopic and open groups. With regard to DFS, we
additionally analyzed locoregional recurrence-free sur-
vival (LRFS) and distant recurrence-free survival (DRFS)
in the entire cohort and in patients with tumor size ≤
4.0 cm. The secondary outcome was the R0 resection
rate. Small T4 colon cancer was defined as tumor size ≤
4.0 cm, which may be advantageous in laparoscopic sur-
gery with small incisions.
OS was defined as the time from surgery to death, and
DFS was defined as the time from surgery to any recur-
rence, secondary cancer, or death. R0 resection was de-
fined as a microscopically margin-negative resection in
which no gross or microscopic tumor remains in the pri-
mary tumor bed. A negative margin was defined as a
margin of normal tissue > 1.0 mm from the edge of the
tumor.
Statistical analyses
Data are reported as mean ± standard deviation or
median (range) for continuous variables and as num-
ber (percentage) for categorical variables. The com-
parison of the variables between the laparoscopic and
open groups was performed using the independent t
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test or Wilcoxon rank sum test and chi-square test or
Fisher’s exact test. Survival curves were analyzed
using the Kaplan–Meier method, and the intergroup
differences were compared using the log-rank test.
The univariate Cox proportional hazards model was
used to determine prognostic factors for OS and DFS.
Variables with p < 0.05 in the univariate analysis were
included in the multivariate analysis. The backward
elimination method, with p > 0.05 as the criterion for
removal, was performed for the multivariate analysis.
After significant clinical variables were adjusted, the
prognosis of the surgical procedure was evaluated. A
p value < 0.05 was considered statistically significant.
Statistical analyses were performed using R (version
3.6.2; The R Foundation for Statistical Computing,
Vienna, Austria) and SAS (version 9.4; SAS Institute
Inc., Cary, NC, USA).
Results
Patient characteristics
A total of 449 patients were included and classified ac-
cording to tumor size; 117 and 332 patients had tumors
of ≤ 4.0 and > 4.0 cm, respectively. In the ≤ 4.0-cm group,
88 and 29 patients underwent laparoscopic and open
surgery, respectively. In the > 4.0-cm group, 194 and 138
patients underwent laparoscopic and open surgery, re-
spectively (Fig. 1). Twenty-one patients who converted
from laparoscopic to open surgery were included in the
open group.
Patients in the laparoscopic group had a higher
BMI (23.7 vs. 22.0 kg/m2, p < 0.001) and a lower pro-
portion of patients in this group had an ASA score of
> 2 (4 vs. 14.1%, p < 0.001) than in the open group.
The proportions of blood loss and postoperative
transfusion were lower in the laparoscopic group than
in the open group (50 vs. 100 mL, p < 0.001, and 0.7
vs. 12.8%, p < 0.001, respectively). Patients in the lap-
aroscopic group had a shorter hospital stay (8 vs. 10
days, p < 0.001) and a lower postoperative morbidity
(18 vs. 29.5%, p = 0.005) than those in the open
group (Table 1).
Pathologic and oncologic outcomes
Patients in the laparoscopic group had smaller tumors
(5.2 vs. 6 cm, p < 0.001) and a lower T4b rate (17.3 vs.
43.0%, p < 0.001) than those in the open group. Angio-
lymphatic, venous, and perineural invasion were more
common in the laparoscopic group than in the open
group (74 vs. 43.0%, p < 0.001; 50 vs. 34.9%, p = 0.003;
and 78 vs. 62.4%, p = 0.001, respectively). Similarly,
the adjacent organ resection rate was lower in the lap-
aroscopic group than in the open group (6 vs. 28.2%,
p < 0.001).
The R0 resection rate did not differ significantly be-
tween the two groups (94.0 vs. 97.3%, p = 0.078;
Table 2). The median follow-up period was 34
months. There were no significant intergroup differ-
ences with regard to the 3-year OS and DFS rates
(83.2 vs. 86.6%, p = 0.180 and 75.1 vs. 71.7%, p =
0.720, respectively; Fig. 2). The 3-year LRFS and
DRFS rates also did not differ significantly between
the two groups (92.4 vs. 90.5%, p = 0.587 and 79.4
vs. 76.8%, p = 0.826, respectively; Fig. 3).
Outcomes of small T4 colon cancer
Table 3 shows the clinical characteristics and periopera-
tive outcomes of patients with tumor size ≤ 4.0 cm. The
laparoscopic group had a higher BMI (23.9 vs. 22.3 kg/
m2, p = 0.026) and less blood loss (50 [0–1000] vs. 50
[0–530] mL, p = 0.03) than the open group. Other vari-
ables did not differ significantly between the two groups.
Table 4 presents the pathologic features and oncologic
outcomes of patients with tumor size ≤ 4.0 cm. Patients
in the laparoscopic group were more likely to have
angiolymphatic invasion than those in the open group
(77.3 vs. 37.9%, p < 0.001).
R0 resection was performed in all patients in both
groups. In patients with tumor size ≤ 4.0 cm, the 3-
year OS rate did not differ significantly between the
two groups (78.7 vs. 83.3%, p = 0.538). However, the
3-year DFS rate was higher in the laparoscopic group
than in the open group (79.2 vs. 53.2%, p = 0.012;
Fig. 4). The 3-year LRFS rate did not differ signifi-
cantly between the two groups (92.7 vs. 91.5%, p =
0.948). In contrast, the DRFS rate was higher in the
laparoscopic group than in the open group (83.8 vs.
55.3%, p = 0.007; Fig. 5).
Discussion
Although the safety of laparoscopic surgery for colon
cancer had been demonstrated in several studies [4–
7], the safety of this surgical approach is controversial
Fig. 1 Flowchart of patient enrollment
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in T4 colon cancer. Several studies have suggested
that a laparoscopic approach in T4 colon cancer may
be feasible in some patients. Few studies have pro-
vided useful indications for laparoscopic surgery in
T4 colon cancer. Klaver et al. [2] reported that lap-
aroscopic surgery for T4a tumors might be safe.
However, the pathologic features would not be helpful
in determining the indication of laparoscopic surgery
preoperatively. Park et al. [13] found the laparoscopic
approach to be feasible for left-sided T4 colon cancer.
Nevertheless, a useful predictor is still necessary to
preoperatively determine the safety of laparoscopic
surgery for T4 cancer.
In this study, the clinicopathologic and oncologic
outcomes of laparoscopic surgery for T4 colon cancer
were generally comparable to those of open surgery.
The laparoscopic approach, especially for small T4 tu-
mors, had better 3-year DFS rates than open surgery.
To adjust for confounding variables, we analyzed the
Cox proportional hazards regression model for OS
and DFS in the entire cohort and in patients with
tumor size ≤ 4.0 cm. Laparoscopic surgery had better
DFS rates in patients with tumor size ≤ 4.0 cm (p =
0.020) (Additional files 1 and 2).
A previous study [14] has reported that malignant
cells are intraoperatively exfoliated from the tumor
Table 1 Patient characteristics and perioperative outcomes
Variable Open (N = 149) Laparoscopy (N = 300) p value
Age (years) 64.9 ± 12.8 63.6 ± 12.6 0.298a
Gender Male 82 (55.0) 172 (57.3) 0.643c
Female 67 (45.0) 128 (42.7)
BMI (kg/m2) 22.0 ± 3.3 23.7 ± 3.5 < .001a
ASA score 1, 2 128 (85.9) 288 (96) < .001c
3, 4 21 (14.1) 12 (4)
Preoperative CEA (ng/ml) 3.3 (0.5–338) 4.3 (0.4–543) 0.126b
Location Right 64 (43.0) 142 (47.3) 0.380c
Left 85 (57.0) 158 (52.7)
Operative time (min) 141 (43–520) 160 (50–460) 0.007b
Blood loss (ml) 100 (0–4000) 50 (0–700) < .001b
Transfusion No 130 (87.3) 298 (99.3) < .001d
Yes 19 (12.8) 2 (0.7)
Hospital stay (days) 10 (5–45) 8 (4–158) < .001b
Postoperative morbidity No 105 (70.5) 246 (82.0) 0.005c
Yes 44 (29.5) 54 (18.0)
Postoperative morbidity type Ileus 7 (15.9) 15 (27.8)
Urinary retention 2 (4.6) 5 (9.3)
Anastomotic leakage 0 (0) 3 (5.6)
Surgical site infection 17 (38.6) 15 (27.8)
Pneumonia 5 (11.4) 2 (3.7)
Sepsis 3 (6.8) 3 (5.6)
Others 10 (22.7) 11 (20.4)
Clavien–Dindo classification 1, 2 34 (77.3) 42 (77.8) 0.953c
3 10 (22.7) 12 (22.2)
Adjuvant chemotherapy (N = 329) No 20 (28.6) 39 (15.1) 0.009 c
Yes 50 (71.4) 220 (78.7)
aTwo-sample t test
bWilcoxon rank sum test
cChi-square test
dFisher’s exact test
Data are expressed as mean ± standard deviation or median (range) for continuous variables and as number (percentage) for categorical variables
ASA American Society of Anesthesiologists, BMI body mass index, CEA carcinoembryonic antigen
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Table 2 Pathologic features and oncologic outcomes
Variable Open (N = 149) Laparoscopy (N = 300) p value
Tumor size (cm) 6 (2–30) 5.2 (0.9–14.5) < .001a
Node state N0 53 (35.6) 85 (28.3) 0.118b
N+ 96 (64.4) 215 (71.7)
T stage T4a 85 (57.0) 248 (82.7) < .001b
T4b 64 (43.0) 52 (17.3)
Angiolymphatic invasion Not identified 85 (57.0) 78 (26.0) < .001b
Present 64 (43.0) 222 (74.0)
Venous invasion Not identified 97 (65.1) 150 (50.0) 0.003b
Present 52 (34.9) 150 (50.0)
Perineural invasion Not identified 56 (37.6) 66 (22.0) 0.001b
Present 93 (62.4) 234 (78.0)
Combined resection No 107 (71.8) 282 (94.0) < .001b
Yes 42 (28.2) 18 (6.0)
R0 resection rate 140 (94) 292 (97.3) 0.078b
Harvested lymph nodes N = 298 29 (5–117) 29 (7–244) 0.677a
Proximal margin N = 447 14 (0.5–174) 10.7 (1.5–119.8) 0.004a
Distal margin 8 (0–125.5) 8.3 (0.4–101) 0.532a
Radial margin N = 100 0.4 (0–8.5) 0.4 (0–4) 0.895a
aWilcoxon rank sum test
bChi-square test
Data are expressed as median (range) for continuous variables and as number (percentage) for categorical variables
Fig. 2 Kaplan–Meier curves comparing survival outcomes between the laparoscopic and open groups. a 3-year OS and b 3-year DFS. DFS,
disease-free survival; OS, overall survival
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during resection and spread to the peritoneal surface
and portal vein system. This can be prevented by
minimizing tumor manipulation, e.g., through laparo-
scopic surgery. Lacy et al. [15] showed better cancer-
related survival with laparoscopic colectomy than
open surgery for non-metastatic colon cancer in a
randomized clinical trial, as did our study. When lap-
aroscopic surgery is conducted by an experienced sur-
geon, tumor spillage, and spread may be prevented in
some patients.
As tumor size increases, some technical challenges
arise with regard to laparoscopic surgery, because it
reduces the working space, narrows the operative
visual field, increases bleeding, and makes the tumor
difficult to remove. Moreover, larger tumors increase
the risk of tumor spillage, thereby increasing peri-
toneal seeding or trocar-site recurrence. Our data
show that the 3-year OS and DFS rates in patients
with tumor size > 4.0 cm are not significantly differ-
ent between the two groups (84.4 vs. 87.8%, p = 0.22
and 80.6 vs. 68.7%, p = 0.091, respectively), suggest-
ing that the laparoscopic approach is more feasible
in patients with small tumors than in those with lar-
ger tumors.
Laparoscopic surgery is better than open surgery
in regard to perioperative outcomes. In previous
studies [1, 16, 17] comparing laparoscopic and open
surgery in T4 colon cancer, laparoscopic surgery was
associated with less intraoperative blood loss, which
has been proven to be a predictor of long-term
survival [18, 19]. Some studies [20, 21] have shown
that hospital stays are shorter in patients who
undergo laparoscopic surgery. In this study, patients
in the laparoscopic group had less intraoperative
blood loss and shorter hospital stays than those in
the open group.
In a previous study [3] of T4 colon cancer, the conver-
sion rate from laparoscopic to open surgery was re-
ported to be in the range of 7.1–28.2%. Converted
patients have high postoperative morbidity and adverse
effects on long-term oncologic outcomes [22]. In the
present study, the overall conversion rate was 7%, and
the conversion rate for patients with tumor size ≤ 4.0 cm
was 2.3%. The low conversion rate might be responsible
for the better oncologic outcomes of laparoscopic
surgery.
In this study, the 3-year DFS rate of patients in
the open group with tumor size ≤ 4.0 cm was 53.2%,
which was much lower than the 75.1% for all pa-
tients in the open group. This result is similar to
that of the study by Huang et al. [23], which re-
ported that a smaller tumor size was associated with
a decreased survival in the T4b subset of colon can-
cer patients. Huang et al. [23] suggested that small
tumors in T4b patients may reflect a more biologic-
ally aggressive phenotype. Another plausible explan-
ation is that surgeons may have conducted more
aggressive surgery for larger tumors. In the present
study, the rate of multi-visceral resection was 28.2%
in the entire open group, but only 6.9% in the small
Fig. 3 Kaplan–Meier curves comparing survival outcomes between the laparoscopic and open groups. a 3-year LRFS and b 3-year DRFS. DRFS,
distant recurrence-free survival; LRFS, locoregional recurrence-free survival
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tumor group. Although R0 resection was accom-
plished in all patients with small tumors, it is pos-
sible that disseminated lesions remained in adjacent
organs. These may have contributed to the worse 3-
year DFS rate in patients with tumor size ≤ 4.0 cm in
the open group.
The limitations of this study are as follows. As this
was a retrospective study, the choice of surgical ap-
proach may have been influenced by the patient’s
condition or tumor progression. First, this study was
conducted on the basis of the pathological T4 in-
stead of the clinical T4, although the former cannot
be used to determine the surgical approach pre-
operatively. Engelmann et al. [24] reported that the
computed tomography accuracy of T4 staging in
colon cancer was only 70–77%, although further
studies are needed in patients with clinical T4 colon
cancer. Second, more patients had higher ASA
scores in the open group. This may have affected OS
or DFS. However, in patients with tumor size ≤ 4.0
cm, there was no intergroup difference in ASA
scores. Third, the T4b rate and number of adjacent
organ resections were higher in the open group.
Thus, it is apparent that open surgery was chosen
for patients with more advanced tumors. However,
there were no intergroup differences in the T4b rate
and number of adjacent organ resections in patients
with tumor size ≤ 4.0 cm.
Table 3 Patient characteristics and perioperative outcomes in patients with tumor size ≤ 4.0 cm
Variable Open (N = 29) Laparoscopy (N = 88) p value
Age (years) 62.2 ± 12.0 65.1 ± 12.8 0.287a
Gender Male 14 (48.3) 46 (52.3) 0.709c
Female 15 (51.7) 42 (47.7)
BMI (kg/m2) 22.3 ± 3.2 23.9 ± 3.2 0.026a
ASA score 1, 2 28 (96.6) 87 (98.9) 0.436d
3, 4 1 (3.5) 1 (1.1)
Preoperative CEA (ng/ml) 2.4 (0.6–54.9) 3.3 (0.4–138) 0.270b
Location Right 12 (41.4) 40 (45.5) 0.702c
Left 17 (58.6) 48 (54.6)
Operative time (min) 75 (45–505) 148 (85–460) < .001b
Blood loss (ml) 50 (0–1000) 50 (0–530) 0.003b
Transfusion No 27 (93.1) 88 (100) 0.060d
Yes 2 (6.9) 0 (0)
Hospital stay (days) 8 (5–36) 8 (4–31) 0.942b
Postoperative morbidity No 23 (79.3) 70 (79.6) 0.978c
Yes 6 (20.7) 18 (20.5)
Postoperative morbidity type Ileus 1 (16.7) 6 (33.3)
Urinary retention 0 (0) 2 (11.1)
Anastomotic leakage 0 (0) 1 (5.6)
Surgical site infection 3 (50) 4 (22.2)
Sepsis 0 (0) 1 (5.6)
Others 2 (33.3) 4 (22.2)
Clavien–Dindo classification 1, 2 6 (100) 14 (77.8) 0.539d
3 0 (0) 4 (22.2)
Adjuvant chemotherapy No 1 (20.0) 18 (22.9) 1.000c
(N = 77) Yes 4 (80.0) 54 (77.1)
aTwo-sample t test
bWilcoxon rank sum test
cChi-square test
dFisher’s exact test
Data are expressed as mean ± standard deviation or median (range) for continuous variables and as number (percentage) for categorical variables
ASA American Society of Anesthesiologists, BMI body mass index, CEA carcinoembryonic antigen
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Fig. 4 Kaplan–Meier curves comparing survival outcomes between the laparoscopic and open groups. a 3-year OS and b 3-year DFS in patients
with tumor size ≤ 4.0 cm. DFS, disease-free survival; OS, overall survival
Table 4 Pathologic features and oncologic outcomes in patients with tumor size ≤ 4.0 cm
Variable Open (N = 29) Laparoscopy (N = 88) p value
Tumor size (cm) 3.5 (2–4) 3.4 (0.9–4) 0.208a
Node state N0 7 (24.1) 22 (25.0) 0.926b
N+ 22 (75.9) 66 (75.0)
T stage T4a 26 (89.7) 85 (96.6) 0.161c
T4b 3 (10.3) 3 (3.4)
Angiolymphatic invasion Not identified 18 (62.1) 20 (22.7) < .001b
Present 11 (37.9) 68 (77.3)
Venous invasion Not identified 19 (65.5) 50 (56.8) 0.409b
Present 10 (34.5) 38 (43.2)
Perineural invasion Not identified 7 (24.1) 11 (12.5) 0.146c
Present 22 (75.9) 77 (87.5)
Combined resection No 27 (93.1) 86 (97.7) 0.256c
Yes 2 (6.9) 2 (2.3)
R0 resection rate 29 (100) 88 (100) -
Harvested lymph nodes N = 83 18 (8–60) 25 (7–107) 0.057a
Proximal margin N = 116 8.5 (2–43) 10.1 (1.5–48) 0.198a
Distal margin 5.5 (0–27.5) 7.5 (0.4–50) 0.241a
Radial margin N = 10 1.4 (0.4–2.3) 1.1 (0.1–4) 0.896a
aWilcoxon rank sum test
bChi-square test
cFisher’s exact test
Data are expressed as median (range) for continuous variables and as number (percentage) for categorical variables
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Conclusions
Although laparoscopic surgery showed similar outcomes
in T4 colon cancer to open surgery, the former appears
to have favorable short-term oncologic outcomes in pa-
tients with tumor size ≤ 4.0 cm. Prospective large-scale
studies are needed to identify improved oncologic out-
comes of laparoscopic surgery for small T4 colon
cancer.
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